<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A murine monoclonal antibody (MoAb 19-24) directed against a human <z:hpo ids='HP_0100242'>sarcoma</z:hpo> antigen was prepared and labeled with 111In by use of the linker 1-(p-isothiocyanatobenzyl)-<z:chebi fb="0" ids="35739">diethylenetriaminepentaacetic acid</z:chebi> (<z:chebi fb="0" ids="18022">SCN</z:chebi>-Bz-<z:chebi fb="0" ids="35739">DTPA</z:chebi>) </plain></SENT>
<SENT sid="1" pm="."><plain>Imaging and biodistribution of this radioimmunocomplex were evaluated </plain></SENT>
<SENT sid="2" pm="."><plain>MoAb P3 was similarly labeled as a negative control </plain></SENT>
<SENT sid="3" pm="."><plain>Of 24 athymic mice bearing s.c. human <z:hpo ids='HP_0100244'>fibrosarcoma</z:hpo>, 12 received 10 microCi of [111In]MoAb 19-24 and 12 received 10 microCi of [111In]MoAb P3 </plain></SENT>
<SENT sid="4" pm="."><plain>The mice were imaged at 24, 48, 68, or 168 hr, after i.p. injection </plain></SENT>
<SENT sid="5" pm="."><plain>Region of interest and biodistribution analysis showed maximum localization of MoAb 19-24 in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> at 72 hr with maximum liver localization of 24 hr </plain></SENT>
<SENT sid="6" pm="."><plain>Analysis of MoAb P3 showed maximum <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> and liver activity at 24 hr </plain></SENT>
<SENT sid="7" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> specificity studies were also conducted in three <z:mp ids='MP_0003815'>nude</z:mp> mice bearing a <z:hpo ids='HP_0100242'>sarcoma</z:hpo> in the left flank and a Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> in the right flank </plain></SENT>
<SENT sid="8" pm="."><plain>Selective uptake was seen in the <z:hpo ids='HP_0100242'>sarcoma</z:hpo> but not in the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> </plain></SENT>
<SENT sid="9" pm="."><plain>The excellent uptake of [111In]<z:chebi fb="0" ids="18022">SCN</z:chebi>-Bz-<z:chebi fb="0" ids="35739">DTPA</z:chebi>-MoAb 19-24 in <z:hpo ids='HP_0100242'>sarcoma</z:hpo> without appreciable liver activity indicates that it may be a useful <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> imaging agent in man </plain></SENT>
</text></document>